252 related articles for article (PubMed ID: 9186315)
1. Long-term results of retropubic permanent 125iodine implantation of the prostate for clinically localized prostatic cancer.
Zelefsky MJ; Whitmore WF
J Urol; 1997 Jul; 158(1):23-9; discussion 29-30. PubMed ID: 9186315
[TBL] [Abstract][Full Text] [Related]
2. Impact of transurethral resection on the long-term outcome of patients with prostatic carcinoma.
Zelefsky MJ; Whitmore WF; Leibel SA; Wallner KE; Fuks Z
J Urol; 1993 Dec; 150(6):1860-4. PubMed ID: 8230519
[TBL] [Abstract][Full Text] [Related]
3. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
4. The effects of local and regional treatment on the metastatic outcome in prostatic carcinoma with pelvic lymph node involvement.
Leibel SA; Fuks Z; Zelefsky MJ; Whitmore WF
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):7-16. PubMed ID: 8270461
[TBL] [Abstract][Full Text] [Related]
5. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation.
Fuks Z; Leibel SA; Wallner KE; Begg CB; Fair WR; Anderson LL; Hilaris BS; Whitmore WF
Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):537-47. PubMed ID: 1869452
[TBL] [Abstract][Full Text] [Related]
6. Biochemical disease-free survival following 125I prostate implantation.
Beyer DC; Priestley JB
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):559-63. PubMed ID: 9112453
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.
Zelefsky MJ; Wallner KE; Ling CC; Raben A; Hollister T; Wolfe T; Grann A; Gaudin P; Fuks Z; Leibel SA
J Clin Oncol; 1999 Feb; 17(2):517-22. PubMed ID: 10080594
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05).
Lawton CA; Hunt D; Lee WR; Gomella L; Grignon D; Gillin M; Morton G; Pisansky TM; Sandler H
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):1-7. PubMed ID: 21470793
[TBL] [Abstract][Full Text] [Related]
9. Nonrandomized evaluation of pelvic lymph node irradiation in localized carcinoma of the prostate.
Perez CA; Michalski J; Brown KC; Lockett MA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):573-84. PubMed ID: 8948341
[TBL] [Abstract][Full Text] [Related]
10. Improved local control and survival for surgically staged patients with locally advanced prostate cancer treated with up-front low dose rate iridium-192 prostate implantation and external beam irradiation.
Stromberg J; Martinez A; Benson R; Garton G; Diokno A; Gonzalez J; Zincke H; Schray M; Edmundson G; Brabbins D
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):67-75. PubMed ID: 8270460
[TBL] [Abstract][Full Text] [Related]
11. Twelve-month prostate-specific antigen values and perineural invasion as strong independent prognostic variables of long-term biochemical outcome after prostate seed brachytherapy.
Ding W; Lee J; Chamberlain D; Cunningham J; Yang L; Tay J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):962-7. PubMed ID: 22494584
[TBL] [Abstract][Full Text] [Related]
12. Failure of open radioactive 125iodine implantation to control localized prostate cancer: a study of 41 patients.
Gottesman JE; Tesh DG; Weissman WD
J Urol; 1991 Nov; 146(5):1317-9; discussion 1319-20. PubMed ID: 1942283
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic pelvic lymph node dissection combined with real-time interactive transrectal ultrasound guided transperineal radioactive seed implantation of the prostate.
Stone NN; Ramin SA; Wesson MF; Stock R; Unger P; Klein G
J Urol; 1995 May; 153(5):1555-60. PubMed ID: 7536266
[TBL] [Abstract][Full Text] [Related]
14. Transperineal permanent seed implantation of "low-risk" prostate cancer: 5-year-experiences in 118 patients.
Block T; Czempiel H; Zimmermann F
Strahlenther Onkol; 2006 Nov; 182(11):666-71. PubMed ID: 17072525
[TBL] [Abstract][Full Text] [Related]
15. Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05).
Lawton CA; DeSilvio M; Lee WR; Gomella L; Grignon D; Gillin M; Morton G; Pisansky T; Sandler H
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):39-47. PubMed ID: 17084551
[TBL] [Abstract][Full Text] [Related]
16. [Brachytherapy in prostatic adenocarcinoma].
Haie-Meder C; Court B; Perrin JL; Wibault P; Lartigau E; Gerbaulet A
Ann Urol (Paris); 1994; 28(6-7):295-301. PubMed ID: 7893114
[TBL] [Abstract][Full Text] [Related]
17. 125Iodine implantation for carcinoma of the prostate: 5-year survival free of disease and incidence of local failure.
Schellhammer PF; el-Mahdi AE; Ladaga LE; Schultheiss T
J Urol; 1985 Dec; 134(6):1140-5. PubMed ID: 4057405
[TBL] [Abstract][Full Text] [Related]
18. Prostate brachytherapy: treatment strategies.
Stone NN; Stock RG
J Urol; 1999 Aug; 162(2):421-6. PubMed ID: 10411050
[TBL] [Abstract][Full Text] [Related]
19. The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.
Potters L; Huang D; Fearn P; Kattan MW
Brachytherapy; 2003; 2(1):26-31. PubMed ID: 15062160
[TBL] [Abstract][Full Text] [Related]
20. Intermediate term biochemical-free progression and local control following 125iodine brachytherapy for prostate cancer.
Stone NN; Stock RG; Unger P
J Urol; 2005 Mar; 173(3):803-7. PubMed ID: 15711273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
